Merck KGaA
MKGAF
$133.31
-$0.20-0.15%
OTC PK
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 7.34% | -3.79% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 7.34% | -3.79% | |||
| Cost of Revenue | 12.55% | -7.56% | |||
| Gross Profit | 3.80% | -1.06% | |||
| SG&A Expenses | 8.51% | -8.57% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | 8.75% | 233.11% | |||
| Total Operating Expenses | 10.14% | -1.71% | |||
| Operating Income | -4.58% | -11.71% | |||
| Income Before Tax | -6.48% | 16.52% | |||
| Income Tax Expenses | -13.92% | 53.72% | |||
| Earnings from Continuing Operations | -4.28% | 8.74% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -7.85% | 1.28% | |||
| Net Income | -4.33% | 8.79% | |||
| EBIT | -4.58% | -11.71% | |||
| EBITDA | -3.45% | -2.07% | |||
| EPS Basic | -4.28% | 8.76% | |||
| Normalized Basic EPS | -6.50% | -21.71% | |||
| EPS Diluted | -4.28% | 8.76% | |||
| Normalized Diluted EPS | -6.50% | -21.71% | |||
| Average Basic Shares Outstanding | -0.06% | 0.03% | |||
| Average Diluted Shares Outstanding | -0.06% | 0.03% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | 23.34% | -- | |||